-
1 Comment
Beyond Medical Technologies Inc is currently in a long term uptrend where the price is trading 17.1% above its 200 day moving average.
From a valuation standpoint, the stock is 888.3% more expensive than other stocks from the Industrials sector with a price to sales ratio of 155.0.
Beyond Medical Technologies Inc's total revenue rose by inf% to $24K since the same quarter in the previous year.
Its net income has increased by 32.3% to $-461K since the same quarter in the previous year.
Finally, its free cash flow grew by 60.9% to $-229K since the same quarter in the previous year.
Based on the above factors, Beyond Medical Technologies Inc gets an overall score of 4/5.
Sector | Industrials |
---|---|
Industry | Pollution & Treatment Controls |
ISIN | None |
CurrencyCode | EUR |
Exchange | F |
Market Cap | 7M |
---|---|
Beta | 3.6 |
Target Price | None |
PE Ratio | None |
Dividend Yield | None |
Beyond Med Technologies Inc. develops and commercializes an on-site treatment system that turns organic waste into clean water in Canada. It offers the Cannavore system, a cannabis waste management system that denatures active pharmaceutical ingredients in the waste streams; the Organivore system, a food waste disposal system that turns food waste into clean water; and the Pharmavore for treatment of waste containing drugs, pharmaceuticals, and illicit substances. The company was formerly known as Micron Waste Technologies Inc. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7FM3.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024